These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 34479

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Opioid combination for cancer pain.
    Mercadante S.
    Br J Cancer; 2004 May 17; 90(10):2049. PubMed ID: 15138492
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cancer pain management.
    Portenoy RK.
    Clin Adv Hematol Oncol; 2005 Jan 17; 3(1):30-2. PubMed ID: 16166965
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Opioid-induced hyperalgesia may be more frequent than previously thought.
    Zylicz Z, Twycross R.
    J Clin Oncol; 2008 Mar 20; 26(9):1564; author reply 1565. PubMed ID: 18349412
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cancer pain demands an integrated approach.
    Fine PG.
    J Support Oncol; 2004 Mar 20; 2(6):503-4. PubMed ID: 16329215
    [No Abstract] [Full Text] [Related]

  • 12. [What is guaranteed in pain therapy of cancer patients?].
    Seitz R, Pflüger KH.
    Internist (Berl); 1993 Jan 20; 34(1):25-9. PubMed ID: 7680022
    [No Abstract] [Full Text] [Related]

  • 13. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA.
    Clin Ther; 2006 Jan 20; 28(1):86-98. PubMed ID: 16490582
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Cancer-related pain].
    Lundorff LE, Eriksen J, Sjøgren P.
    Ugeskr Laeger; 2006 May 15; 168(20):1960-2. PubMed ID: 16768893
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of pain in cancer with systemically administered opioids].
    Vielvoye-Kerkmeer AP, van der Weide M.
    Ned Tijdschr Geneeskd; 2001 Aug 04; 145(31):1519-20. PubMed ID: 11512424
    [No Abstract] [Full Text] [Related]

  • 17. Opioids for management of breakthrough pain in cancer patients.
    Potter MB.
    Am Fam Physician; 2006 Dec 01; 74(11):1855-7. PubMed ID: 17168339
    [No Abstract] [Full Text] [Related]

  • 18. [Suggestions concerning modification of traditional 3-stage schedule of drug therapy of chronic pain in incurable oncologic patients].
    Osipova NA, Chissov VI.
    Anesteziol Reanimatol; 1994 Dec 01; (4):30-2. PubMed ID: 7802314
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The 2002 Lindberg Award. PRN vs regularly scheduled opioid analgesics in pediatric burn patients.
    Patterson DR, Ptacek JT, Carrougher G, Heimbach DM, Sharar SR, Honari S.
    J Burn Care Rehabil; 2002 Dec 01; 23(6):424-30. PubMed ID: 12432319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.